GLP-1 receptor agonists show anti-cancer benefits beyond weight loss, reports research Dr. Kamal Kant Kohli17 May 2025 9:15 AM ISTNew research being presented at this year's European Congress on Obesity (ECO) in Malaga, Spain (11-14 May) and published in the journal...
Aficamten Shows Promise Over Metoprolol in Phase 3 MAPLE-HCM Trial for Obstructive HCM Dr. Kamal Kant Kohli17 May 2025 9:00 AM ISTTopline results were released from the phase 3 MAPLE-HCM trial, which compared aficamten with metoprolol in 175 adults with symptomatic obstructive...
Thalidomide-Hydroxyurea Combo More Effective for Sickle Cell Anemia, suggests research Dr. Shravani Dali17 May 2025 8:30 AM ISTResearchers have found in recent clinical trial conducted in India that combining thalidomide with hydroxyurea (HU) significantly outperformed HU...
Oveporexton Boosts Wakefulness and Cuts Cataplexy in Narcolepsy Type 1, Phase 2 Trial Finds Medha Baranwal17 May 2025 8:15 AM ISTFrance: A new phase 2 clinical trial published in The New England Journal of Medicine has shown that oveporexton (TAK-861), an oral orexin receptor...
Cervical Cancer Screening: Vaginal Self-Sampling Outshines Urine in Accuracy, Study Finds Medha Baranwal16 May 2025 8:45 PM ISTChina: A recent meta-analysis published in the International Journal of Gynecology & Obstetrics has found that both vaginal and urine...
Non-Invasive and Cost-Effective: PLR Shows High Accuracy in Identifying Liver Fibrosis in HCV, Study Finds Medha Baranwal16 May 2025 8:30 PM ISTPakistan: Recent research published in the Cureus Journal has identified the platelet-to-lymphocyte ratio (PLR) as a reliable, non-invasive marker for...
Long-COVID patients show signs of inflammation on PET/ MRI scans: Study Dr. Shravani Dali16 May 2025 8:30 PM ISTLong-COVID patients show signs of inflammation on PET/ MRI scans suggests a new study published in the Jouenal of Nuclear Medicine.The objective of...
Lupin Rivaroxaban Tablets approved by USFDA Ruchika Sharma16 May 2025 12:23 PM ISTMumbai: Global pharma major Lupin Limited has received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated...
Diabetes Incidence Surges 62 Percent in India: Study Highlights Alarming Rise, Regional Gaps, and Future Burden Medha Baranwal16 May 2025 9:45 AM ISTIndia: India is facing a rapidly escalating diabetes crisis, with significant state-wise differences in disease burden and projections indicating an...
Communication Key to Tackling India's Diabetes Burden, Indian Researchers Find Medha Baranwal16 May 2025 9:30 AM ISTIndia-A new review published in Apollo Medicine sheds light on an often-overlooked yet essential component of diabetes care-communication. The article...
Weight Loss Injections Linked to Rapid Weight Regain Post-Treatment: Study Finds Dr. Bhumika Maikhuri16 May 2025 8:00 AM ISTNew Delhi: A new analysis by the University of Oxford has found that people taking GLP-1 weight loss drugs typically regain all the weight they lost...
FDA Expands Approval of Belzutifan for Treatment of pheochromocytoma or paraganglioma Dr. Kamal Kant Kohli16 May 2025 7:45 AM ISTThe US food and Drug Administration (FDA) has expanded the approval of Belzutifan (Welireg) to treat specific types of pheochromocytoma or...
